Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 191 M188 M170 M192 M180 M181 M 723 M Research & development —————— — Operating income 435 M483 M663 M621 M606 M716 M 2.61 B Non-Operating Income, Total -16 M-75 M57 M54 M77 M66 M 254 M Interest expense, net of interest capitalized 132 M131 M132 M127 M123 M123 M 505 M Non-Operating Income, excl. Interest Expenses -148 M-206 M-75 M-73 M-46 M-57 M -251 M Unusual income/expense —————— — Pretax income 305 M351 M534 M494 M483 M592 M 2.1 B Equity in earnings 5 M5 M2 M-1 M2 M2 M 5 M Taxes 82 M87 M94 M220 M38 M-73 M 279 M Non-controlling/minority interest 62 M74 M121 M42 M107 M158 M 428 M After tax other income/expense -11 M-20 M-13 M-5 M11 M-4 M -11 M Net income before discontinued operations 223 M264 M440 M274 M445 M665 M 1.82 B Discontinued operations -2 M-1 M-4 M-119 M00 -123 M Net income 221 M263 M436 M155 M445 M665 M 1.7 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 221 M263 M436 M154 M445 M665 M 1.7 B Basic earnings per share (Basic EPS) 0.490.580.960.330.981.46 3.73 Diluted earnings per share (Diluted EPS) 0.490.570.960.330.971.45 3.71 Average basic shares outstanding 326 M328 M328 M329 M347 M348 M — Diluted shares outstanding 456 M457 M457 M457 M459 M460 M — EBITDA 458 M508 M686 M696 M629 M739 M 2.75 B EBIT 435 M483 M663 M621 M606 M716 M 2.61 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 23 M25 M23 M75 M23 M23 M 144 M